Article Versions Notes

Scano M, Benetollo A, Dalla Barba F, Akyurek EE, Carotti M, Sacchetto R, Sandonà D. Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy—Assessment of Patient’s Primary Myotubes. International Journal of Molecular Sciences. 2024; 25(24):13313. https://doi.org/10.3390/ijms252413313

Scano, Martina, Alberto Benetollo, Francesco Dalla Barba, Eylem Emek Akyurek, Marcello Carotti, Roberta Sacchetto, and Dorianna Sandonà. 2024. "Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy—Assessment of Patient’s Primary Myotubes" International Journal of Molecular Sciences 25, no. 24: 13313. https://doi.org/10.3390/ijms252413313

Scano, M., Benetollo, A., Dalla Barba, F., Akyurek, E. E., Carotti, M., Sacchetto, R., & Sandonà, D. (2024). Efficacy of Cystic Fibrosis Transmembrane Regulator Corrector C17 in Beta-Sarcoglycanopathy—Assessment of Patient’s Primary Myotubes. International Journal of Molecular Sciences, 25(24), 13313. https://doi.org/10.3390/ijms252413313